[{"Assets_0_Q2_USD":42359200000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1954000000.0,"NetIncomeLoss_1_Q2_USD":-259900000.0,"NetIncomeLoss_2_Q2_USD":957500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1030200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1041600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1030200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1039600000.0,"StockholdersEquity_0_Q2_USD":11555200000.0,"EarningsPerShareBasic_1_Q2_USD":-0.25,"EarningsPerShareBasic_2_Q2_USD":0.92,"EarningsPerShareDiluted_1_Q2_USD":-0.25,"EarningsPerShareDiluted_2_Q2_USD":0.92,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282856619893.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20180725"}]